Neuberg Diagnostics launches NCGM, its first Laboratory in the USA

~ Neuberg becomes the first lab chain of Indian origin to start direct operations in the USA with CLIA certified lab operations ~

~ Unites key collaborators under one umbrella for molecular and genomics based new generation testing ~

May 03, 2021: Neuberg Diagnostics, a global laboratory testing group, announced the start of its clinical laboratory operations in North Carolina in the United States of America (USA). The laboratory in North Carolina, known as NCGM, Inc. (Neuberg Centre for Genomic Medicine), will focus on genomic and molecular testing based on new generation sequencing techniques. It also runs an extensive network of labs in India, South Africa, and the UAE as well.

NCGM has introduced COVID-19 molecular testing to detect active SARS CoV-2 virus infections that is of immediate public health priority in North America, along with genome scale testing, such as Exome Sequencing, which is applicable across a variety of Rare Genetic Disease Testing (Inherited Diseases) from Newborn Screening to Oncology to Pediatric Care Setting.

Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics, said, “NCGM, USA will act as the laboratory and hub, aiding our operations in the North America. Through leveraging our collaborative efforts across our organization in India, South Africa, and UAE, and with our external partners, we aim to develop and provide the best-in-class affordable tests. As they are deployed, the accessibility and affordability of the tests will reduce disparity and benefit individuals across the board.”

Dr Sandip Shah, Executive Director Neuberg Diagnostics, said “NCGM, USA Sequencing services will be supported by in-house bioinformatics team and cutting-edge technologies which has been developed inhouse, and along with reputed partners. It will also support genetic research by leveraging our own extensive infrastructure in India, South Africa, and UAE.”

Dr. Andy Bhattacharjee, CEO, NCGM, USA, said, “The setup has comprehensive Genomic testing facility allowing large-scale clinical and research projects. With capacity to conduct more than 400 variety of tests, the center will conduct large-scale clinical diagnostics and genomics projects with greater sample volumes at an unprecedented depth and coverage of the genome. Currently we are offering Covid RT-PCR Testing Services at our NC Lab with home sample collection facilities in association with FexEx to help fight the pandemic in USA too. “

For more information about NCGM, USA, please visit – http://www.ncgm.us/ or write to us at contactncgm@neubergdiagnostics.com or call us at 252 371 1584

City Today News
9341997936

STAR INDIA LAUNCHES A NEW CAMPAIGN FOCUSSING ON THE REAL HD EXPERIENCE

STAR INDIA LAUNCHES A NEW CAMPAIGN FOCUSSING ON THE REAL HD EXPERIENCE
The TVC ‘SIRF DIKHAANE KE LIYE NAHI, DEKHNE MEIN BHI REAL HD EXPERIENCE’ will air across the Star India Network in 7 languages

Mumbai, April 30, 2021: Star India has launched a new network-wide television campaign (TVC) ‘SIRF DIKHAANE KE LIYE NAHI, DEKHNE MEIN BHI REAL ‘HD’ EXPERIENCE to build awareness among television lovers who, despite owning an HD TV and HD Set-Top Box (STB), continue to view their favourite Star channels in Standard Definition (SD).

Consumers often think that having an HD TV by itself provides the complete HD viewing experience, which is a myth the campaign aims to bust with a touch of humor. Based on the findings from a study conducted by Star India, only 25%* of consumers are aware of the fact that apart from having an HD TV and an HD Set-Top box they also need to subscribe to HD channels to get the complete HD viewing experience.
The campaign also highlights the features of Star HD channels such as wider picture, 5x sharper picture, and 5.1 Dolby surround sound that help make the viewing experience far more superior and immersive, ‘Taaki aapka HD TV sirf ‘dikhaane’ ke liye hee nahi, dekhne mein bhi Real HD experience de!’

Gurjeev Singh Kapoor, President – TV Distribution, India and International, Star And Disney India, said, “At Star India, we have always focused on providing an unparalleled entertainment experience and value to our viewers. There is a huge potential to further increase affinity towards our content with the large portfolio of 26 Star HD channels across genres and languages; with a strong live cricketing calendar this year and VIVO IPL 2021 just around the corner, we want consumers to experience the sheer delight and stadium-like feeling that our HD channels can provide. It is the right time for consumers to enhance their viewing experience with a Star HD channel subscription. Hence, this campaign is aimed at bridging the awareness gap and in helping consumers realize the relevance of recharging their Star HD channels.”

The campaign is driven by a well-conceptualized film that draws a parallel to people’s innate habit of keeping things in their homes for show value rather than using it for their intended purpose. Owning a fancy, flat-screen HD TV is something that elevates the social status of an individual, and the campaign cheekily nudges the consumer to elevate the value of their HD TV ‘Apne HD TV Ka Naam Roshan Kijiye’ by subscribing to Star HD channels. The campaign will also feature some of the most loved characters from the Star India Network endorsing the Real HD experience.

*study conducted amongst decision maker in TV channel packs subscription across 10,000+ Pay TV households in 2019, across 69 towns
**conditions apply

ANNEXURE
Star Network offers a holistic range of HD channels across genres & languages.

Channel Genre
Star Plus HD Hindi GEC
Star Bharat HD Hindi GEC
Star Gold HD Hindi Movies
Star Gold Select HD Hindi Movies
UTV HD Hindi Movies
Star Jalsha HD Bengali GEC
Jalsha Movies HD Bengali Movies
Vijay HD Tamil GEC
Star Suvarna HD Kannada GEC
Asianet HD Malayalam GEC
Star Movies HD English Movies
Star World HD English GEC
Star Movies Select HD English Movies
Disney International HD English GEC
Star Sports HD1 Sports
Star Sports HD2 Sports
Star Sports 1 HD Hindi Sports
Star Sports Select HD1 Sports
Star Sports Select HD2 Sports
Maa HD Telugu GEC
Maa Movies HD Telugu Movies
Star Pravah HD Marathi GEC
Baby TV HD Kids
National Geographic HD Infotainment
Nat Geo Wild HD Infotainment
Fox Life HD Infotainment

City Today News
9341997936

Made-in-India Virus Attenuation Device Shycocan launched in UAE to Help Curb Spread of Coronavirus

Invented by well-known scientist Dr. Rajah Vijay Kumar, the world’s first virus-attenuation device aims to get life and businesses back to normal amidst the pandemic

The device is proven to disable the Coronavirus and Influenza virus strains in indoor spaces, which carry the highest risk of transmission

Shycocan is scientifically evidenced to attenuate/neutralise 99.9% of both airborne and surface-borne Coronavirus family and Influenza family of viruses

Shycocan also works on all current and future variants and mutants of these viruses, ensuring a safe environment for both B2B and B2C

NEW DELHI / April 27, 2021: Shycocan, a breakthrough virus-attenuation device invented and manufactured in India, has been launched in the UAE at the International Conference of Pharmacy & Medicine (ICPM) held at Sharjah. This marks the Middle East debut of the product, the first of its kind in the world, that is seeing a robust demand from institutional buyers across the world in times of the raging Coronavirus pandemic.

The cylindrical device, Shycocan, is scientifically evidenced to neutralise and help curb the spread of the Coronavirus and Influenza family of viruses in indoor spaces with 99.9% efficacy, enabling schools, colleges, homes and businesses like hospitals, hotels, offices, restaurants, auditoriums, transportation, retail and airports get back to normal and serve the customers in a safe environment.

Remarkably, Shycocan also works on all current and future variants and mutants of these viruses, protecting people’s health and saving millions of hours of lost productivity.

Alok Sharma, Chief Executive Officer, Shycocan Corporation, said, “The world faced one of its biggest challenges with the pandemic, bringing us all to a standstill. More livelihoods than lives have been lost, in fact, close to a billion at the last count. Science, technology and innovation are going to play a big role in helping us reclaim our lives and work safely. We are delighted to launch the pathbreaking one- of-a-kind virus-attenuation device, the Shycocan, in the UAE in the hope of helping people bring lives and businesses back to normal. And we couldn’t have found a more credible and relevant platform than the prestigious ICPM to showcase our cutting-edge technology.”

Shycocan is distributed in the UAE for consumers and business customers by Redington Middle East LLC and Ibn Batuta Medicine & Medical Equipment Store LLC. It is one of the most thoroughly tested devices for both safety and efficacy. It neither uses nor emits radiation, chemicals, ozone or any toxic material. It is 100% safe for humans, animals and the environment. Additionally, it does not harm the bacterial ecosystem and microbes that thrive in the environment and are essential for our immunity.

Said the well-known scientist Dr. Rajah Vijay Kumar, the inventor of Shycocan,“Coronavirus-type outbreaks are occurring with faster intermittent frequencies. The COVID-19 strain is getting more infectious and deadlier with successive mutations in the last 17 years, underscoring the importance of a device like Shycocan. The biggest challenge of this virus is its infectivity or virulence. Breaking the chain of infectivity requires focused work on indoor environments because they carry the highest risk of transmission. In 2017, our campus in Bengaluru experienced many incidents of seasonal flu, compelling me to design, build and install the device which was later christened Shycocan. A year later, the incidence of seasonal flu was almost totally absent from the campus. When the COVID-19 pandemic struck, the device was sent for testing and regulatory compliances to global laboratories and found to be equally effective against it. It was overwhelming to realise that we had already created the world’s first technology to fight the pandemic long before imagining the possibility of such a crisis taking the entire world in its grip.”

Shycocan has widespread usage across market segments, including hospitals, clinics, schools, higher education institutions, banking sector, manufacturing and retail outlets, hospitality sector, government offices, real estate corporations and businesses. In addition, the company offers customised consultations, a one-year replacement warranty, strong support and service network across the UAE, and a post-installation audit.

A single device when mounted has an effective coverage area of 1,000 square feet (10,000 cubic feet). Multiple devices can be installed to cover a larger indoor space. The device has seen a robust demand from institutional buyers across the globe and is already in use in countries such as India, the US, Europe, Malaysia, Australia, New Zealand and South Africa, among others.

Dr Abdullah Al Kindi, Chairman & CEO, ICPM, said, “Mankind is facing one of the most challenging times – something that has impacted lives, livelihoods and businesses at a global scale. We as global citizens need the best of science, technology, social responsibility, and willpower to fight it – and triumph. ICPM was established with responsibility towards humanity and with healthcare as its foundation. It gives me immense pleasure to launch Shycocan on this platform. It is a product with innovative technology and the capability to bring businesses and lives back to normal.”

City Today News
9341997936

Shield30, a Next-Gen Sanitization Technology that Provides 99.99% Protection from Surface-borne Covid Infection, Launched

28 April 2021: Even as the daily caseload of India’s coronavirus infections, during the second wave, exceeds more than two lakhs, Shield30, a disruptive sanitization technology, is launched in India. This revolutionary, water-based antimicrobial surface treatment technology from New Zealand provides 99.99% protection from surface-borne infection of Coronaviruses and a host of other pathogens.

Surface transmission continues to pose a significant risk, as the Covid virus spreads through contaminated surfaces, known as fomites. Studies show that SARS-CoV-2 can persist on plastic and stainless steel for up to 6 days. It lasts for days on any hard materials including books, textile products – synthetic or natural made, and even on surgical masks. Hence, frequent disinfection of surfaces and objects in common places that are routinely used by several people is important. The need of the hour also is a breakthrough in the methods of disinfection that replaces chemical based sanitizers, which are harmful for the environment, and are also not very safe for people, children and pets. 

As opposed to the conventional, chemical-based sanitizers, Shield30 is a water-based solution and contains no harmful chemicals or alcohol. It is safe for use near people, animals, and plants. Shield30 does not rely on dehydration or poison to kill pathogens. Instead, it forms a covalent bond, which resembles a layer of millions of nano-sized “pins”, on the surfaces and other frequently used things like doorknobs, chairs, and medical equipment. The pins attract the pathogens including coronaviruses and a host of other bacteria, mold, and fungi, and pierce and rupture their cellular structures and kill them. For each application, the protection lasts for nearly 30 days. 

One of the prominent users of Shield30 is Meenakshi Mission Hospital and Research Centre, Madurai. Dr. S. Gurushankar, its chairman said that Shield30 provides 99.99% protection for patients, doctors, and staff against surface-borne infection of viruses, germs and bacteria. The hospital covers its entire premises right from the reception to operation theatres with Shield30 disinfectant solution. Medically, a big benefit of the ‘physical’ killing approach of Shield30 is that for the pathogens there is nothing to learn and develop their resistance and become superbugs, over time.

Shield30 can play a key role in reducing the economic impact of the Covid-19 pandemic, when the manufacturing and services industries, especially the travel, hospitality, restaurant, and hospital units, use it as their disinfectant solution. 

In many countries in Europe and North America, restaurants are fumigated with Shield30 in order to destroy any traces of the virus, and thus attract customers. In a Shield30-sanitized restaurant if a customer walks in with coronavirus it would be killed as soon as he or she touches anything in it. Major aircraft now use Shield30 disinfectant with a focus on high contact areas – seats, seatbelts, overhead lockers, air vents and toilets.

Shield30 is certified by over 100 international labs for its effectiveness in killing the virus. Shield30 disinfectant solutions can be bought from all ecommerce platforms such as Amazon, Flipkart and Shield30 website (www.shield30.in), retail stores like pharmacy outlets, premium markets, hypermarkets and malls

City Today News
9341997936

Generic Aadhaar Reached Exclusively as Medicine Reliever in Bangalore when India again got Hit by Covid-19 Tsunami Wave…

Bangalore, April 27, 2021: 19years old , Arjun Deshpande’s Generic Aadhaar is a rapidly growing Indian Pharma Company starts its Exclusive Retail Franchise Medical Store in 24th main near Nandhini Delux, JP Nagar, Phase-6, Bengaluru also known as “Bangalore City”. When the world was gradually healing from the Corona Virus pandemic early this year but now the situation is more likely changed and seems devastated to witness the worsening of covid crisis in India. Many have lost their lives due to the critical situations of not getting the required medicines and injections on time where the demand has risen higher to topmost and supply is limited. Thus, Generic Aadhaar has encouraged the Women Entrepreneurs also to join the impactful Mission of being job creator then being the job seeker…

To Join our AATMANIRBHAR GENERIC AADHAAR Mission call now: 9653373636

Where Generic Aadhaar have distributed life Saving “REMDESIVIR INJECTION” for free of Cost, when some were making money out of this heartfelt situation. Setting a better healthcare’s vision for India at this young age and to stand with the people gives a right courageous example for the future of India. The Young Founder did not stop here he also distributed the “FREE FIRST AID KIT” to the Frontline Workers the Covid Warriors Maharashtra Police Officers who works for hours in the hot climate & Safe guards the Citizens from Infringement in the city. Generic Aadhaar medical stores across India will sooner get the Good Quality with Highest Discounted Medical Store of LIFE SAVING MEDICINES and promises to provide more 500+ stores in the Bengaluru City and many more in the State of Karnataka.

The Innovative Pharma Venture was Started by 16yrs young Mr. Arjun Deshpande, is India’s youngest entrepreneur founded and named Generic Aadhaar, back in 2018 from Mumbai Maharashtra & also the venture is supported and backed by renowned Industrialist Mr. Ratan Tata Sir himself. Generic Aadhaar is a Pharma Venture that Provides highest Discount up to 80-90% on Medicines which will be beneficial for people of Bengaluru and will result in Saving their harden money on Life Saving Drugs. Generic Aadhaar will Definitely help Common man’s monthly budget in this very tough covid crisis.

As per statistics, about 60% of Indians cannot afford to buy their daily medicines, gauging the market requirements, he already visualised the old traditional pharma industry to be changed as it was the need of the hour and emerged as a change Maker for betterment. He has the ability and courage to do something out of the box he was solely on the mission of making medicines available to every Indian at affordable price. After the business buzz and several Free Health check-up campaigns about the young founder’s Venture the great business entrepreneur Mr. Ratan Tata noticed and got impressed to joined hands with him to support his vision of unique and Innovative Pharma Venture for providing better Healthcare in India. Now, they are on Same Mission.

Generic Aadhaar Founder Mr. Arjun Deshpande said while Virtually Inaugurating Bangalore Store…. “I feel proud and will not stop to serve the nation on their right to get lifesaving drugs with easy availability with affordability. We are focusing on providing Job Opportunities by providing entrepreneurship through our franchise stores across India and we are aiming to provide Good Quality Generic Medicines for people of Bangalore. I promised to start 500+ stores in the City in few months. We are here for the People and appealing all Indians to choose generic medicines which are good in quality and efficacy and are much effective as they are approved drugs. Covid-19 Corona Virus Pandemic has taught us a Lesson that “Health is the biggest Wealth “. Also feeling Energised when Women of India is Coming forward in our Mission and Being known as an Independent Women Entrepreneur in the Locality…. he Concluded.

Generic Aadhaar Master Franchise Bengaluru city (South and East Zone) Mrs Nisha Tondon….” It’s a Privilege to be part of this innovative impactful mission, also feels honour to be independent women entrepreneur now. This was only because of the Young Entrepreneur Mr Arjun Deshpande Sir who has given us the opportunity of heading in the Bengaluru city (South and East Zone) for the betterment of People living in the Locality. Definitely this innovative idea should reach out to all Indians, Iam Proud to associate today with the rapidly growing Pharma Company Generic Aadhaar.”

City Today News
9341997936